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’ INTRODUCTION
Proteases and peptidases (EC 3.4) are enzymes that catalyze
the hydrolysis of peptide bonds. They constitute approximately
2% of the human genome and are involved in many physiological
processes such as cell-cycle progression, tissue remodeling,
coagulation, wound healing, cell proliferation, and cell death, as
well as the immune response.1 Their involvement in these
biological processes makes proteases very important drug targets.
Furthermore, proteases are important biocatalysts for a wide
range of industrial applications. Understanding the enzymatic
mechanism and the factors determining their substrate speciﬁcity
is therefore of crucial importance for the characterization of their
medical relevance as well as for obtaining optimized biocatalysts.
To assay enzyme activity and substrate speciﬁcity, ﬂuorogenic
probes are commonly used.24 The chemical modiﬁcation of a
ﬂuorophore with one or two enzyme-cleavable bonds alters its
photophysical properties and results in a nonﬂuorescent deriva-
tive. The ﬂuorescence is recovered upon enzymatic cleavage.
Peptide-based substrate analogues can further be designed based
on photoinduced electron transfer5 or ﬂuorescence resonance
energy transfer.6,7 Fluorescence is often chosen as a detectable
signal as it provides high sensitivity in vitro. Moreover, ﬂuores-
cent probes also ﬁnd widespread application in living cells and
tissues where they provide high spatial and temporal resolution.
The choice of ﬂuorophore is critical for the design of a good
enzyme substrate analogue, and favorable ﬂuorescent molecules
have to meet several requirements: (i) high brightness to obtain
high sensitivity, (ii) ﬂuorescence excitation above 450 nm to
reduce photodamage in biological molecules and to avoid
interference with autoﬂuorescence of biological samples, and
(iii) no interference with the enzymatic reaction so that the
kinetic parameters remain unaltered.8 Although frequently used,
Coumarin-based substrate analogues have a low brightness and are
excited below 450 nm. Common ﬂuorophores which possess the
aforementioned properties and are often used for introducing an
enzyme-cleavable bond are ﬂuorescein, resoruﬁn, and 7-hydroxy-
9H-(1,3-dichloro-9,9-dimethylacridin-2-one) (DDAO) for esterases,
phosphoesterases, and glycosidases. Fluorophores used for
proteases are Rhodamine 110 and cresyl violet. The latter,
however, yields only substrate analogues with insuﬃcient stability
to autohydrolysis in aqueous solutions.9 Except for resoruﬁn and
DDAO, these substrate analogues contain two sites for conjugating
the enzyme-cleavable group.1012 Using the double-substituted
pro-ﬂuorescent derivatives for kinetic measurements complicates a
Received: February 25, 2011
Revised: July 13, 2011
ABSTRACT: Commonly used ﬂuorogenic substrate analogues
for the detection of protease activity contain two enzyme-
cleavable bonds conjugated to the ﬂuorophore. Enzymatic
cleavage follows a two-step reaction with a monoamide inter-
mediate. This intermediate shows ﬂuorescence at the same
wavelength as the ﬁnal product complicating the kinetic analysis
of ﬂuorescence-based assays. Fluorogenic substrate analogues
for α-chymotrypsin with one cleavable peptide bond have been prepared frommorpholinecarbonyl-Rhodamine 110 (MC-Rh110).
A comparison of their kinetic properties with the corresponding (peptide)2-Rh110 derivatives revealed that these frequently used
double-substituted substrate analogues yield only apparent Km and kcat values that are quite diﬀerent from the kinetic parameters
obtained from the monosubstituted MC-Rh110 based substrate analogues. Although both the monoamide intermediate and MC-
Rh110 are monosubstituted Rhodamine 110 derivatives, they show diﬀerent spectroscopic properties. The data from the
spectroscopic analysis clearly show that these properties are directly related to the electron structure of the ﬂuorophore and not
to the previously proposed equilibrium between the lactone form and the open ionic form of the ﬂuorophore. This knowledge about
the determinants of the spectroscopic properties of monosubstituted Rhodamine 110 introduces a way for a more systematic
development of new ﬂuorogenic protease substrate analogues.
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quantitative analysis, since full ﬂuorescence manifestation re-
quires the cleavage of two bonds involving an intermediate with a
diﬀerent ﬂuorescence intensity.
The diﬃculty of quantifying the kinetic constants of such a two-
step reaction has been addressed in several studies, and solutions
have been proposed to obtain the kinetic constants.13,14 These
approaches, however, always require the detection of the inter-
mediate concentration, which is often not possible in a ﬂuores-
cence measurement due to the overlap of the excitation and
emission spectra of the intermediate and the ﬁnal product. Other
assays to determine the intermediate concentration such as
HPLC might not be considered feasible especially in high-
throughput assays or measurements in cellular systems. As a
consequence, eﬀorts are being made to synthesize monosubsti-
tuted substrate analogues, and a number of examples exist
utilizing Rhodamine 110 (Rh110).
The most obvious solution might be to attach only one
peptide to the Rh110 core. Although this yields a stable molecule,
the applicability of such amonoamide Rh110 derivative is limited
by its ﬂuorescence, which is approximately still 10% relative to
Rh110.15 Hence, it is desirable to develop Rh110-based substrate
analogues that have no intrinsic ﬂuorescence while possessing
only one enzyme cleavable bond. This has been achieved by
modifying one of the amino groups with a nonhydrolyzable
blocking group while attaching a peptide to the second amino
group. Initially designed to increase cell permeability, a range of
diﬀerent blocking groups have been investigated, but they mostly
yield dye molecules with a relative ﬂuorescence intensity of only
515% compared to Rh110.1618 The best blocking group
known to date, which preserves much of the high ﬂuorescence
of Rh110, introduces a urea functionality into Rh110.19 Origin-
ally designed byWang et al.,20 morpholinecarbonyl-Rh110 (MC-
Rh110) is a promising candidate for developing sensitive mono-
amide substrate analogues.
Although Rh110 has been used for many years to synthesize
substrate analogues for proteases, the properties of the mono-
substituted derivatives have never been investigated system-
atically. Double-substitution of Rh110 yields a nonﬂuorescent
lactone. Consequently, it has been proposed in several reports
that the ﬂuorescence of monosubstituted Rh110 is determined
by an equilibrium between a nonﬂuorescent monosubstituted
lactone form and an open zwitterionic ﬂuorescent form of
the molecule. It was further suggested that the electron with-
drawing character of the substituent inﬂuences this equilibrium
and therefore the ﬂuorescence intensity of the respective
derivative.18,20
Using α-chymotrypsin as the model system, we determined
the enzyme kinetic parameters for diﬀerent MC-Rh110 based
substrate analogues and compared them with conventional bis-
amide Rh110 substrate analogues. Furthermore, we performed a
systematic analysis of the photophysical properties ofMC-Rh110
and monoamide Rh110 in order to understand why diﬀerent
substituents on one of the amino-groups of Rh110 yield deriva-
tives with diﬀerent ﬂuorescence intensity.
’EXPERIMENTAL PROCEDURES
Synthetic Approaches. Unless stated otherwise, reagents
were obtained from Sigma-Aldrich or Acros. The substrate
analogues were purified on a Waters 996 HPLC with a Waters
600 controller. Reversed-phase C18 columns (Alltech Previal
or Phenomenex Luna, both 15 cm long with 2.1 mm diameter
and 5 μm particle size) were used. MPLC chromatography was
performed using a B€uchi Sepacore Flash apparatus. Mass
spectra were run using Thermo Finnigan LCQ Advantage
apparatus (ESI). NMR spectra were acquired on commercial
instruments (Bruker Avance 300 MHz, Bruker AMX 400 MHz
or Bruker Avance II+ 600 MHz with TXI probe or TCI
CryoProbe) and chemical shifts (δ) are reported in parts per
million (ppm) referenced to tetramethylsilane (1H) or the
internal (NMR) solvent signals (13C). Rhodamine 110 (99%
pure, laser grade, Acros) was used for the synthesis of the
substrate analogues.
(suc-AlaAlaProPhe)2-Rh110; (sucAAFP)2-Rh110.The synthesis
of (sucAAPF)2-Rh110was performed as described in the Supporting
Information of De Cremer et al.21 and verified by ESI and NMR
spectrometry.
MC-Rh110. The synthesis of MC-Rh110 was based on the
method described in the patent application by Diwu et al.22 Since
the described purification procedure using a silica gel column did
not yield pure product, the dye was purified with MPLC using a
mixture of EtOAc/CHCl3/MeOH (50:47.5:2.5). Yield: 25%.
MS (ESI+): 444 (MH+). 1HNMR (600MHz, CDCl3): δ (ppm)
7.99 (d, J = 7.9 Hz, 1H; H-60), 7.65 (t, J = 7.5 Hz, 1H; H-50), 7.59
(t, J = 7.5 Hz, 1H; H-40), 7.50 (s, 1H; H-5), 7.15 (d, J = 7.6 Hz,
1H; H-30), 6.83 (d, J = 6.8 Hz, 1H; H-7), 6.63 (d, J = 8.6 Hz, 1H;
H-8), 6.53 (d, J = 8.3Hz, 1H; H-1), 6.51 (s, 2H;H-4), 6.34 (d, J =
6.8 Hz, 1H; H-2), 3.90 (sb, 2H; NH2), 3.74 (t, J = 4.7 Hz, 4H;
H-2a, 6a), 3.49 (t, J = 4.7 Hz, 4H; H-3a, 5a). 13C NMR (125
MHz, CDCl3): δ (ppm) 169.8 (C; COO), 154.7 (C; CO), 153.4
(C; C-6), 152.8 (C; C-11), 152.1 (C; C-14), 149.0 (C; C-3),
141.0 (C; C-20), 135.1 (CH; C-40), 129.7 (CH; C-1), 129.2 (CH;
C-8), 128.5 (CH; C-50), 126.9 (C; C-10), 125.0 (CH; C-60),
124.2 (CH; C-30), 115.2 (CH; C-7), 113.6 (C; C-13), 111.7
(CH; C-2), 108.6 (C; C-12), 107.6 (CH; C-5), 101.6 (CH; C-4),
84.1 (C; C-9), 66.6 (CH2; C-2a, 6a), 44.4 (CH2; C-3a, 5a).
1H NMR (600 MHz, D2O + 5% DMSO-d6): δ (ppm) 8.02
(d, J = 7.3 Hz, 1H; H-60), 7.89 (s, 1H; H-5), 7.78 (t, J = 7.3 Hz,
1H; H-50), 7.75 (t, J = 7.3 Hz, 1H; H-40), 7.45 (d, J = 8.6 Hz, 1H;
H-8), 7.44 (d, J = 8.6 Hz, 1H; H-1), 7.40 (d, J = 7.3 Hz, 1H,
H-30), 7.36 (d, J = 8.6 Hz, 1H; H-7), 7.00 (d, J = 10.6 Hz, 1H;
H-2), 6.95 (s, 1H; H-4), 3.82 (t, J = 4.6 Hz, 4H; H-2a, 6a), 3.82
(t, J = 4.6 Hz, 4H; 3a, 5a). Carbon signals as derived from
HSQC and HMBC NMR measurements (D2O + 5% DMSO-
d6): δ (ppm) 164 (COO
), 160.8 (C-3), 160 (C-14), 159.8
(C-11), 156 (CO), 155.1 (C-6), 147.6 (C-9), 137.8 (C-10), 133
(C-1), 131.3 (C-20), 130.4 (C-8), 130.2 (C-40) 129.9 (C-50),
129.6 (C-30), 128.9 (C-60), 118.7 (C-2), 118.1 (C-7), 116(C-
13), 116.1 (C-12), 105.4 (C-5), 97.4 (C-4), 66.1 (C-2a, 6a),
44.3 (C-3a, 5a). (See Chart 1 for atom numbering and molecular
structure in diﬀerent solutions.)
Chart 1
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suc-AlaAlaProPhe-Rh110-MC; sucAAPF-Rh110-MC. TBTU
(N,N,N0,N0-tetramthyl-o-(benzotriazol-1-yl)uranium tetrafluoro-
borate) was obtained from Novabiochem and Boc-(L)-AlaAla-
Pro-OH from Bachem. A mixture of TBTU (215 mg, 0.7 mmol)
and DIPEA (350 μL, 2 mmol) was dissolved in 1 mL of dry DMF
and added to Boc-L-Phe-OH (180 mg, 0.7 mmol) dissolved in
2mL of dry CH2Cl2 under Ar. MC-Rh110 (50mg, 0.1mmol) was
dissolved in 1 mL dry CH2Cl2 and slowly added to the reaction.
After 17 h of stirring, the solvents were evaporated and the crude
mixture was directly purified by HPLC using an acetonitrile/water
gradient (12100% ACN). Yield: 40% (30 mg, 0.04 mmol) Boc-
Phe-Rh110-MC. MS (ESI+): 692 (MH+).
Deprotection of Phe was achieved by slow addition of 50/50
(v/v) TFA/CH2Cl2 (3 mL) to Boc-Phe-Rh110-MC (30 mg,
0.04 mmol) in CH2Cl2 (1.5 mL). After 3 h, the reaction was
stopped and concentrated under vacuum. MS (ESI+): 592
(MH+).
TBTU (32 mg, 0.1 mmol) and DIPEA (40 μL, 0.2 mmol)
were dissolved in 1 mL of dry DMF and added to a solution of
Boc-(L)-AlaAlaPro-OH (35 mg, 0.1 mmol in 3 mL dry THF),
kept at 0 C under Ar. The reaction mixture was stirred for 10
min after which it was left to warm to room temperature. The
Phe-Rh110-MC was dissolved in 1 mL of dry THF and added
to the above mixture. After stirring the reaction mixture at
37 C for 12 h, the solvents were evaporated and the mixture
was puriﬁed by HPLC (45% ACN in water; isocratic). Yield:
52% (21 mg, 0.02 mmol) Boc-AlaAlaProPhe-Rh110-MC. MS
(ESI+): 931 (MH+).
The Boc group was removed as described above and the
deprotected product was succinylated in 4 mL THF using
triethylamine (25 μL, 0.2 mmol) and succinic anhydride (10
mg, 0.1 mmol) at 37 C for 10 h. The mixture was puriﬁed by
HPLC (35% ACN in water; isocratic). Yield: 67% (14 mg,
0.015 mmol). MS (ESI+): 931 (MH+), 953 (MNa+). 1H NMR
(300MHz, DMSO): δ (ppm) 9.98 (d, J = 5.4 Hz, 2H), 8.86 (s,
2H), 8.098.00 (m, 8H), 7.86 (dd, J = 1.7 Hz, J = 4.9 Hz, 2H),
7.80 (t, J = 7.3 Hz, 2H), 7.73 (t, J = 7.3 Hz, 2H), 7.68 (d, J = 1.9
Hz, 2H), 7.307.14 (m, 20H), 6.74 (d, J = 8.7 Hz, 2H), 6.66
(d, J = 8.7 Hz, 2H), 4.58 (dd, J = 1.7 Hz, J = 4.9 Hz, 2H), 4.51
(t, J = 7.0 Hz, 2H), 4.284.21 (m, 4H), 3.62 (d, J = 1.9 Hz,
2H), 7.307.14 (m, 20H), 6.74 (d, J = 8.7 Hz, 2H), 3.15 (dd,
J = 4.7 Hz, J = 14.7 Hz, 2H), 2.93 (dd, J = 9.4 Hz, J = 13.7 Hz,
2H), 2.402.31 (m, 8H), 1.991.92 (m, 2H), 1.811.76 (m,
4H), 1.681.63 (m, 2H), 1.191.14 (m, 14H).
(suc-Phe)2-Rh110; (suc-F)2-Rh110. (Boc-Phe)2-Rh110 was
obtained as the product of the first step of the synthesis of (suc-
AAPF)2-Rh110. It was deprotected and succinylated as described
above. After purification by HPLC (37% ACN in water; iso-
cratic), the desired (suc-F)2-Rh110 was obtained. MS (ESI+):
826 (MH+). 1H NMR (600 MHz, DMSO): δ (ppm) 10.39 (s,
2H), 8.38 (d, J = 7.9 Hz, 2H), 8.02 (d, J = 7.5 Hz, 1H), 7.88 (2s,
2H), 7.79 (t, J = 7.5 Hz, 1H), 7.72 (t, J = 7.5 Hz, 1H), 7.287.21
(m, 10H), 7.207.18 (m, 2H), 6.73 (d, J = 8.7 Hz, 2H), 4.62 (s,
2H), 3.07 (d, J = 9.4 Hz, 2H), 2.87 (t, J = 9.7 Hz, 2H), 2.382.24
(m, 8H). 13C NMR (125 MHz, DMSO): δ (ppm) 173.8 (C),
171.3 (C), 170.8 (C), 168.5 (C), 150.6 (C), 140.8 (C), 137.4
(C), 135.4 (CH), 130.0 (CH), 128.9 (CH), 128.2 (CH), 127.9
(CH), 126.2 (CH), 125.6 (C), 124.7 (CH), 123.7 (CH), 115.5
(CH), 113.1 (C), 106.4 (CH), 81.6 (C), 54.8 (CH), 37.3 (CH2),
30.0 (CH2), 29.7 (CH2).
suc-Phe-Rh110-MC; suc-F-Rh110-MC. Boc-Phe-Rh110-MC
was obtained as the product of the first step of the synthesis of
suc-AAPF-Rh110-MC. Deprotection and succinylation was per-
formed as described above. The purified product was eluted from
HPLC using 35% ACN in water (isocratic). MS (ESI+): 692
(MH+). 1H NMR (400 MHz, DMSO): δ (ppm) 10.51 (s, 1H),
8.78 (s, 1H), 8.39 (d, J = 6.5 Hz, 2H), 7.94 (d, J = 7.8 Hz, 1H),
7.90 (s, 1H), 7.72 (t, J = 7.3Hz, 1H), 7.65 (t, J = 7.3Hz, 1H), 7.59
(S, 1H), 7.387.35 (m, 1H), 7.217.17 (m, 5H), 7.127.09 (m
2H), 6.64 (Sbr, 2H), 6.60 (t, J = 8.3 Hz, 4H), 4.504.48 (m, 1H),
3.54 (t, J = 4.3 Hz, 5H), 3.37 (t, J = 4.8 Hz, 5H), 3.07 (dd, J = 4.0
Hz, J = 13.7 Hz, 2H), 2.80 (dd, J = 9.8 Hz, J = 13.4 Hz, 2H), 2.6
(s, 1H), 2.262.01 (m, 5H).
Boc-Phe-Rh110; Boc-F-Rh110.During the synthesis of (Boc-
Phe)2-Rh110, monosubstituted Boc-F-Rh110 was obtained as a
side product after silica chromatography. It was further purified
by HPLC using an ACN/water gradient (10100% ACN). MS
(ESI+): 579 (MH+). NMR: 1H NMR (600 MHz, CDCl3): δ
(ppm) 7.99 (d, J = 7.5 Hz, 1H), 7.687.56 (m, 3H), 7.30 (d, J =
6.8 Hz, 1H), 7.297.21 (m, 3H), 7,14 (d, J = 6.8 Hz, 1H), 6.79
(sb, 1H), 6.65 (d, J = 8.3Hz, 1H), 6.556.51 (m, 2H), 6.34 (d, J =
7.9 Hz, 1H), 5.10 (s, 1H), 4.44 (s, 1H), 3.90 (s, 2H), 3.15 (s, 2H),
1.42 (s, 9H). 13CNMR (125MHz, CDCl3): δ (ppm) 177.6 (C),
169.8 (C), 153.4 (C), 152.6 (C), 152.0 (C), 149.0 (C), 139.2
(C), 135.0 (CH), 129.7 (CH), 129.4 (CH), 129.3 (CH), 129.1
(CH), 128.7 (CH), 127.4 (CH), 127.0 (C), 125.1 (CH), 124.1
(CH), 115.2 (CH), 111.8 (CH), 108.6 (C), 108.0 (CH), 101.6
(CH), 100.1 (C), 83.5 (C), 56.8 (CH), 38.1 (CH2), 28.4 (CH3).
Boc-AlaAlaProPhe-Rh110; Boc-AAPF-Rh110.For the synth-
esis of this compound, the coupling of Boc-AlaAlaPro-OH to
Phe-Rh110 was not possible, as the peptide might also react with
the second amino group of Rh110. Instead, the 4 amino-acid-
long peptide Boc-AlaAlaProPhe-OH was coupled to Rh110
directly. In the first step, the peptide Boc-AlaAlaProPhe-OH
was synthesized. Boc-AlaAlaPro-OH (200 mg, 0.6 mmol) was
dissolved in 10 mL of anhydrous THF at 0 C. To this solution, a
mixture of TBTU (180 mg, 0.6 mmol) and DIPEA (130 μL, 0.7
mmol), dissolved in 2 mL dry DMF, was added. After 10 min, the
cooling bath was removed and the reaction mixture was allowed
to warm to room temperature. Phe-OMe (160 mg, 0.7 mmol),
dissolved in 4 mL dry DMF, was added slowly to the above
mixture. After 20 h of stirring, the solvents were evaporated and
the crude mixture was purified on a silica gel column using
CH2Cl2/MeOH (9:1) as the eluent. Removal of the methyl
group was carried out in CH2Cl2 and 0.3 M NaOH. After that,
the reaction was neutralized by HCl and again purified on a silica
gel column using CH2Cl2/MeOH (9:1) as the eluent. Yield: 83%
(250 mg, 0.5 mmol). MS (ESI+): 527 (MNa+).
Boc-AlaAlaProPhe-OH (53 mg, 0.1 mmol), TBTU (41 mg,
0.1 mmol) andDIPEA (75 μL, 0.4mmol) were dissolved in 2mL
of dry DMF. To this mixture, Rhodamine 110 chloride (22 mg,
0.06 mmol in 1 mL dry DMF) was added and the solution was
stirred overnight at 37 C. The resulting mixture was evaporated
and puriﬁed by HPLC (40% ACN in water; isocratic). The yield
was only 2% (1.2 mg). MS (ESI+): 818 (MH+). This low yield
was expected, as it has been shown before that the coupling of the
complete 4 amino-acid-long peptide is much less eﬃcient than
the sequential coupling of amino acids in a multistep reaction.18
Kinetic Measurements. Chymotrypsin (α-Chymotrypsin
from bovine pancreas; Fluka) was dissolved in PBS (10 mM
phosphate pH 7.4, 138 mM NaCl, 2.7 mM KCl; Sigma).
Substrates were prepared as stock solutions in DMSO. Reactions
were started by adding 190 μL of chymotrypsin in PBS to
10 μL of a substrate solution in the cuvette. The final enzyme
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concentration was 3 nM for (suc-AAPF)2-Rh110 and suc-AAPF-
Rh110-MC or 900 nM for (suc-F)2-Rh110 and suc-F-Rh110-
MC. The substrate concentrations varied between 0.4 and 50
μM. Product formation was followed by recording fluorescence
(λex = 488 nm; λem = 520 nm) with a Photon Technology
International fluorescence spectrometer. The emission intensity
was converted into product concentrations using calibration
curves of Rh110 or MC-Rh110, respectively. Km, kcat, and
kcat/Km values were obtained by least-squares fitting of the data
to theMichaelisMenten equation usingOrigin (see Supporting
Information).
Determination of the Absorption and Emission Spectra.
Rhodamine 110 chloride (Bioreagent, Sigma) was used to study
the photophysical properties. Absorption measurements were
performed with a Lambda 40 UV/vis spectrometer (Perkin-
Elmer). For the fluorescence measurements, a Photon Technol-
ogy International fluorescence spectrometer was used.
Fluorescence Lifetime Measurements. Excited-state life-
times were determined using time-correlated single photon count-
ing (TCSPC). The instrument response function (IRF) was
recorded using a LUDOX scattering solution and its fwhm
amounted to∼40 ps. The fluorescence decay curves were analyzed
by being fitted to a convolution of the IRFwith a decay function for
a δ-pulse using a TRFA Global Analysis Program based on a
Marquard-Levenberg least-squares fitting. The quality of the fit was
judged according the criteria published by Boens et al.23
Determination of the Quantum Yield. Quantum yield mea-
surements were performed with an integrating sphere using a
Fluorolog 3 fluorescence spectrometer (Horiba Jobin Yvon).
The procedure as well as the calculations are described in the work
of de Mello.24 The measurements of the fluorophore solutions
(absorption between 0.07 and 0.15) were performed in triplicate.
’RESULTS AND DISCUSSION
For the enzyme activity measurements, the following substrate
analogues were synthesized: (suc-AAPF)2-Rh110, suc-AAPF-
Rh110-MC, (suc-F)2-Rh110, and suc-F-Rh110-MC. These mol-
ecules were nonﬂuorescent and stable in aqueous solution. No
autohydrolysis could be detected. The bis-amide substrate
analogues (suc-AAPF)2-Rh110 and (suc-F)2-Rh110 are hydro-
lyzed by the enzyme following the two-step reaction shown in
Scheme 1. The hydrolysis of the monoamide substrate analogues
suc-AAPF-Rh110-MC and suc-F-Rh110-MC follows the reac-
tion of Scheme 2.
Enzymatic activity was measured over a range of substrate
concentrations (at least 12 data points) in order to determine
the kinetic constants. At least one reaction in each series was
followed to completion. In this way, the ﬁnal product concen-
tration could be determined, which corresponds directly to the
initial substrate concentration. This approach yields an accurate
value of the substrate concentration even if the respective
compound contains noncleavable components such as mol-
ecules with D-amino acids that have not been completely
removed during puriﬁcation.
The results (Table 1) clearly show that the activity of α-
chymotrypsin is higher for the substrate analogues containing
the AAPF sequence instead of phenylalanine only. It has been
observed before that the activity of α-chymotrypsin increases
with increasing length of the peptide.25 More interesting are,
however, the diﬀerences between the peptide-Rh110-MC and
the bis-amide Rh110 substrate analogues. For both the 4 amino-
acid-long and the 1 amino-acid-long peptides, the kcat values for
the peptide-Rh110-MC based substrate analogue are higher
than for the (peptide)2-Rh110 substrate analogue. This is
expected when considering that the cleavage of the bis-amide
substrate analogue (Scheme 1) involves the less ﬂuorescent
intermediate. When using the ﬂuorescence of the product as the
calibration, the actual number of cleaved bonds is underesti-
mated due to the presence of the intermediate leading to a lower
measured reaction velocity and kcat
app value. The lower Km
app
values for the (peptide)2-Rh110 substrate analogues can po-
tentially result from a higher eﬀective molarity of the cleavable
Scheme 1. Two-Step Enzymatic Hydrolysis of the Fluorogenic Substrate Analogue (suc-AAPF)2-Rh110 into the Fluorescent
Product Rhodamine 110 Showing the Production of the Less Fluorescent Intermediate
Scheme 2. One-Step Enzymatic Hydrolysis of the Fluorogenic Substrate Analogue (suc-AAPF)-Rh110-MC into the Fluorescent
Product MC-Rh110
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bonds or rebinding of the intermediate after hydrolysis of the
ﬁrst bond. Although we cannot exclude that the MC-moiety
inﬂuences the binding of the substrate analogues to the enzyme,
it appears likely that the kinetic parameters obtained from the
hydrolysis of the monoamide peptide-Rh110-MC substrate
analogue represent the true kinetic constants related to pep-
tide-bond cleavage. The result that the determined kcat
app and
Km
app values for the double-substituted substrate analogue do
not resemble the real kinetic constants is further supported by
the observation that the two cleavage steps are characterized by
diﬀerent kinetic constants as has been shown for other ﬂuoro-
genic substrate analogues before.13
Making several assumptions, we have also made an attempt to
calculate the individual kinetic constants of the two-step hydro-
lysis reaction (see Supporting Information). While the calculated
kcat/Km values for the individual reaction steps have a large error,
they are clearly diﬀerent from each other and from the apparent
values. This further emphasizes the problem associated with
obtaining kinetic constants for double-substituted substrate
analogues. In summary, these results show that the apparent
Km
app and kcat
app values determined for the double-substituted
Rh110 substrate analogues are not the true rate constants
characterizing the enzymatic reaction. Clearly, there is no
accurate way to determine these from an assay purely based on
ﬂuorescence. Monosubstituted substrate analogues such as pep-
tide-Rh110-MC are required for an accurate determination of
Km and kcat.
In order to obtain a more detailed picture of the molecular
mechanism determining the ﬂuorescence of MC-Rh110, we also
synthesized the monosubstituted peptide-Rh110 derivatives. We
expected that a comparison of MC-Rh110 with Boc-F-Rh110
and Boc-AAPF-Rh110 as well as with Rh110 would give insight
into the properties determining the high ﬂuorescence intensity of
MC-Rh110. The Boc-protected analogues were used instead of
the succinylated peptides, because they are easier to obtain in
high purity, which is essential for spectroscopic measurements.
The Boc-group is not expected to aﬀect the structural and
photophysical properties as it has been shown before that only
the amino acid closest to the ﬂuorophore determines its
properties.26 The latter is conﬁrmed by our measurements that
show similar photophysical properties for Boc-F-Rh110 and Boc-
AAPF-Rh110 (see Supporting Information).
For bothMC-Rh110 and Boc-F-Rh110, we have observed that
their solutions in chloroform do not absorb visible light. This
suggests their presence in the nonﬂuorescent lactone form,
which is conﬁrmed by NMR spectra. The 1H signals for protons
1, 2, 7, and 8 of the xanthene moiety are shielded, and the carbon
13C signal at 84 ppm corresponds to carbon 9 (see Supporting
Information). Combining the 13C and DEPT spectra indicates
that the number of carbons is compatible with the presence of a
single molecular species. When these molecules are dissolved in
water, however, they absorb in the blue region with a maximum
absorption coeﬃcient of 24 600 and 52 000 M1 cm1 for Boc-
F-Rh110 and MC-Rh110, respectively. NMR measurements of
MC-Rh110 in D2O/DMSO (5%) conﬁrm the formation of the
open zwitterionic form and do not indicate the presence of more
than one species. The carbon signals of the benzene ring and C-2,
3 of the xanthene moiety show very similar ppm values as for
unsubstituted Rh110 (see Supporting Information).27 X-ray
diﬀraction analysis of MC-Rh110 single-crystals, obtained from
the slow evaporation of a methanol solution, also revealed the
open ionic conformation. Methanol as a medium corresponds to
a polar environment just as in an aqueous solution. In conclusion,
we suggest that the previously proposed conformational equi-
librium of monosubstituted Rh110 molecules is completely
shifted to the lactone form in a nonpolar solution. In contrast,
all molecules adopt the open ionic form in a water solution. This
result is further supported by the photophysical properties of
Boc-F-Rh110 and MC-Rh110 that obviously suggest a diﬀerent
reason for the decrease in ﬂuorescence intensity from Rh110 to
MC-Rh110 and Boc-F-Rh110.
The data presented in Figure 1 and Table 2 show that the
attachment of a substituent to one of the amino groups of Rh110
leads to a blue shift of the absorption maximum, a red shift of the
emission maximum, an increased bandwidth, and vibrational
progression in the absorption and emission spectra. This is
accompanied by a decrease of the ﬂuorescence quantum yield.
This eﬀect is more pronounced for Boc-F-Rh110 than for MC-
Rh110. These results can be rationalized by considering the
Table 1. Kinetic Parameters for the α-Chymotrypsin Cata-
lyzed Hydrolysis of the Substrate Analogues with One and
Two Cleavable Peptide Bonds
substrate analogue kcat [s
1] Km [μM]
kcat/Km
[M1 s1]
(suc-AAPF)2-Rh110
apparent
0.43( 0.03 8.7( 1.6 (5.0( 1) 104
suc-AAPF-Rh110-MC 11( 1 68( 7 (16( 2) 104
(suc-F)2-Rh110 apparent 0.0035( 0.0003 31( 4 (1.1( 0.2) 102
suc-F-Rh110-MC 0.054( 0.006 182( 23 (3.0 ( 0.5) 102
Figure 1. (A) Absorption and (B) emission spectra of Rhodamine 110, morpholinecarbonyl-Rh110, and BocF-Rh110; (C) normalized emission
spectra of Rhodamine 110 and its monosubstituted peptide derivative.
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resonance forms of the dyes. For Rh110, two equivalent and iso-
energetic resonance forms exist with the positive charge on the
left and right amino groups, respectively. For MC-Rh110, the
attachment of an electron withdrawing amide moiety to one of
the amino groups destabilizes the resonance form with the
positive charge on the corresponding amino group. For Boc-F-
Rh110, this resonance form is even more destabilized as the
electron withdrawing character of the carbonyl is no longer
attenuated by the electron donating morpholino moiety. As
both resonance forms are no longer iso-energetic, there is an
alternation of single and double bonds in the xanthenium cation
leading to a blue shift of the absorption. Furthermore, the
alternation of single and double bonds increases upon excita-
tion which leads to increased electron phonon coupling and
hence increased vibrational progression. The asymmetry
furthermore leads to a dipole moment along the long axis of
the molecule that is diﬀerent in the excited state and the ground
state. This diﬀerence in dipole moment leads to an increased
Stokes shift and hence a red shift of the ﬂuorescence. Further-
more, the increased asymmetry of the π-cloud results in a
reduced transition dipole moment between the S0 and S1 states
that is reﬂected in the ﬂuorescent rate constant. The molar
extinction coeﬃcient at the maximum shows an even stronger
decrease resulting from the combination of an increased
electron phonon coupling and a decreased transition dipole
moment. Finally, the increased electron phonon coupling also
leads to an increase of the nonradiative decay rate from 7.5 
106 s1 in Rh110 over 1.1  108 s1 in MC-Rh110 and 2.5 
108 s1 in Boc-F-Rh110. Finally, it should be noted that the
ﬂuorescence lifetimes measured at both maxima of Boc-F-
Rh110 are the same, indicating that they must be attributed
to the same emitting species. Overall, our results clearly suggest
that the diﬀerences in ﬂuorescence intensity do not originate
from the proposed equilibrium between a lactone form and a
zwitterionic form but result from diﬀerences in the electron
structure of the monosubstituted Rh110 derivatives.
The absence of this equilibrium is important information
for single molecule experiments, where it is essential that the
ﬂuorophore population studied is homogeneous. Thus, the
chemical properties of MC-Rh110 in principle make it an
ideal ﬂuorophore for preparing substrate analogues with 1:1
stoichiometry for the analysis of enzyme kinetics at the single
molecule level. However, not only the chemical properties
ensure that each generated product molecule can be detected
individually as a ﬂuorescent signal.21,28 MC-Rh110 further
shows suﬃcient brightness to be detected at the single
molecule level. It is therefore our next goal to investigate if
suc-AAPF-Rh110-MC and (suc-AAPF)2-Rh110 also yield
diﬀerent kinetic parameters in single molecule experiments
where the intermediate is probably not detected due to its low
brightness.
In conclusion, we have synthesized a series of ﬂuorogenic
substrate analogues for α-chymotrypsin. We have shown that
only substrate analogues with one cleavable bond give access
to the real kinetic constants of the enzymatic reaction. The
origin of the relatively high ﬂuorescence of the morpholine-
carbonyl monosubstituted Rh110 was established. We antici-
pate that the ﬂuorescence of monosubstituted ﬂuorescein
derivatives is determined by the same mechanism and that
in aqueous solution xanthene dyes in general adopt an open
ionic form. This information is vital for the development of the
next generation of monosubstituted ﬂuorogenic substrate
analogues, e.g., with improved solubility or cell permeability,
which might ultimately allow the study of single enzyme
molecules in living systems.
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Table 2. Spectroscopic Properties of Rhodamine110 and Its Monoderivatives
molecule ﬂuorescence lifetime [ns] Φ488 λmax abs [nm] λmax em [nm] ε488 [M
1 cm1] Fl. Int (rel)a
Rhodamine110 4.0 0.97 495 69 000 1
(2.4  108)b (0.05 523
(7.5  106)c
MC-Rh110 3.6 0.60 492 52 000 0.3
(1.7  108)b (0.03 525
(1.1  108)c
Boc-Phe-Rh110 2.8 0.31 489 24 600 0.1
(1.1  108)b (0.02 529
(2.5  108)c
a λex = 488 nm, λem = 520 nm.
b kf [s
1]. c knr [s
1].
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